Position in LRMR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,027,132
+$1,894,244 QoQ
Shares Held
1,561,585
+15.9% QoQ
Ownership
1.50%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
17 quarters on record
Voting authority
Sole 99%
Shared 1%
None 0%
Common Shares in LRMR Over Time
Shares Held
Position Value (USD)
Derivatives in LRMR
reported options exposure · as of Mar 31, 2026CallValue
$405,000
CallShares
90,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. LRMR ranks #158 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in LRMR
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $405,000 | 90,000 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $7,027,132 | 1,561,585 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,132,888 | 1,347,215 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $5,087,251 | 1,575,001 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $380,387 | 131,622 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,743,231 | 2,671,271 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $16,069,122 | 4,152,228 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $27,834,165 | 4,249,491 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $31,412,749 | 4,332,793 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $25,939,568 | 3,417,598 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $609,094 | 133,867 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $535,623 | 135,601 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $422,853 | 135,097 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $801,270 | 176,881 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $465,393 | 112,686 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $194,976 | 60,930 | Shares | Defined | 2024-05-14 | |
| 2021-09-30 | $150,501 | 13,053 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $140,563 | 14,314 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||